Hybrid closed-loop systems are increasingly gaining recognition as a gold-standard option for diabetes management, and medtech makers are jumping at the opportunity to add their own artificial ...
A clinical trial of an artificial pancreas system showed it was able to outperform current treatments for people with Type 1 diabetes and help maintain blood sugar levels throughout the day as well as ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, Dexcom, Inc.
Frans Cromme, Chief Executive Officer of ViCentra, said: "We aim to deliver the best user experience as well as excellent clinical results with our Kaleido insulin pump and our partners. Kaleido with ...
SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod Horizon. It is designed to be compatible ...
Kaleido is one of the world's smallest and lightest insulin patch pumps, with a low ecological footprint due to its reusable design Paired with the Diabeloop DBLG1 control software and Dexcom G6 CGM ...
Kaleido is one of the world's smallest and lightest insulin patch pumps, with a low ecological footprint due to its reusable design Paired with the Diabeloop DBLG1 control software and Dexcom G6 CGM ...
ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest insulin patch pump systems for managing type 1 diabetes, is pleased to announce the launch of a Hybrid Closed Loop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results